Efficacy and safety of Cadonilimab plus anlotinib in small cell lung cancer with brain metastases
PurposeThis study aimed to evaluate the efficiency and safety of Cadonilimab and Anlotinib pairing in individuals diagnosed with small cell lung cancer (SCLC) and brain metastases (BMs).MethodsA review was performed on individuals who were diagnosed with small cell lung cancer (SCLC) and had central...
Saved in:
| Main Authors: | Hai-Zhen Yi, Wei Lv, Jin-Jing Chen, Zhan Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1545101/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Cadonilimab plus anlotinib with radiotherapy for lung adenocarcinoma with pancreatic metastasis in later-line therapy
by: Jianquan Yang, et al.
Published: (2025-07-01) -
The Efficacy of Anlotinib Plus Whole Brain Radiotherapy in Advanced Non‐Small Cell Lung Cancer With Multiple Brain Metastases: A Retrospective Study
by: Lipin Liu, et al.
Published: (2025-01-01) -
Stereotactic radiosurgery combined with anlotinib for limited brain metastases with perilesional edema in non‐small cell lung cancer: Rvision‐001 study protocol
by: Yuxia Wang, et al.
Published: (2020-05-01) -
A phase II study of anlotinib plus whole brain radiation therapy for patients with NSCLC with multiple brain metastases
by: Dayong Gu, et al.
Published: (2024-12-01) -
The efficacy and safety of a novel PD‐1/CTLA‐4 bispecific antibody cadonilimab (AK104) in advanced non‐small cell lung cancer: A multicenter retrospective observational study
by: Hongxin Li, et al.
Published: (2024-11-01)